Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Filing Details

Accession Number:
0001181431-14-006845
Form Type:
4
Zero Holdings:
No
Publication Time:
2014-02-13 18:55:22
Reporting Period:
2014-02-11
Filing Date:
2014-02-13
Accepted Time:
2014-02-13 18:55:22
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1485003 Eleven Biotherapeutics Inc. EBIO Pharmaceutical Preparations (2834) 252025616
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1222012 Noubar Afeyan 1 Memorial Drive, 7Th Floor
Cambridge MA 02142
Yes No No No
1255927 Jr M Edwin Kania 1 Memorial Drive, 7Th Floor
Cambridge MA 02142
No No Yes No
1503559 Flagship Ventures Fund Iv, L.p. 1 Memorial Drive
Cambridge MA 02142
No No Yes No
1508051 Flagship Ventures Fund Iv General Partner Llc 1 Memorial Drive, 7Th Floor
Cambridge MA 02142
No No Yes No
1508052 Flagship Ventures Fund 2007, L.p. 1 Memorial Drive, 7Th Floor
Cambridge MA 02142
No No Yes No
1508053 Flagship Ventures 2007 General Partner Llc 1 Memorial Drive, 7Th Floor
Cambridge MA 02142
No No Yes No
1590973 Flagship Ventures Fund Iv-Rx, L.p. 1 Memorial Drive, 7Th Floor
Cambridge MA 02142
No No Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2014-02-11 1,417,323 $0.00 1,692,913 No 4 C Direct
Common Stock Acquisiton 2014-02-11 926,017 $0.00 1,041,427 No 4 C Direct
Common Stock Acquisiton 2014-02-11 231,504 $0.00 260,356 No 4 C Direct
Common Stock Acquisiton 2014-02-11 214,095 $10.00 1,907,008 No 4 P Direct
Common Stock Acquisiton 2014-02-11 131,722 $10.00 1,173,149 No 4 P Direct
Common Stock Acquisiton 2014-02-11 32,912 $10.00 293,268 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 C Direct
No 4 C Direct
No 4 C Direct
No 4 P Direct
No 4 P Direct
No 4 P Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Series A Convertible Preferred Stock Disposition 2014-02-11 9,000,000 $0.00 1,417,323 $0.00
Common Stock Series A Convertible Preferred Stock Disposition 2014-02-11 4,200,000 $0.00 661,417 $0.00
Common Stock Series A Convertible Preferred Stock Disposition 2014-02-11 1,050,000 $0.00 165,354 $0.00
Common Stock Series B Convertible Preferred Stock Disposition 2014-02-11 1,680,213 $0.00 264,600 $0.00
Common Stock Series B Convertible Preferred Stock Disposition 2014-02-11 420,053 $0.00 66,150 $0.00
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 No 4 C Direct
0 No 4 C Direct
0 No 4 C Direct
0 No 4 C Direct
0 No 4 C Direct
Footnotes
  1. Held by Flagship Ventures Fund 2007, L.P. ("Flagship 2007"). Flagship Ventures 2007 General Partner LLC ("Flagship 2007 LLC") is the general partner of Flagship 2007. Noubar B. Afeyan, Ph.D. and Edwin M. Kania, Jr. are the managers of Flagship 2007 LLC. Flagship 2007 LLC and each of these individuals may be deemed to share voting and investment power with respect to all shares held by Flagship 2007. Each of the filing persons disclaims beneficial ownership of such shares except to the extent of his or its pecuniary interest therein. Mr. Afeyan is a member of the Issuer's board of directors.
  2. Held by Flagship Ventures Fund IV, L.P. ("Flagship IV"). Flagship Ventures Fund IV General Partner LLC ("Flagship IV LLC") is the general partner of Flagship IV. Noubar B. Afeyan, Ph.D. and Edwin M. Kania, Jr. are the managers of Flagship IV LLC. Flagship IV LLC and each of these individuals may be deemed to share voting and investment power with respect to all shares held by Flagship IV. Each of the filing persons disclaims beneficial ownership of such shares except to the extent of his or its pecuniary interest therein. Mr. Afeyan is a member of the Issuer's board of directors.
  3. Held by Flagship Ventures Fund IV-Rx, L.P. ("Flagship IV-Rx"). Flagship IV LLC is the general partner of Flagship IV Rx. Noubar B. Afeyan, Ph.D. and Edwin M. Kania, Jr. are the managers of Flagship IV LLC. Flagship IV LLC and each of these individuals may be deemed to share voting and investment power with respect to all shares held by Flagship IV-Rx. Each of the filing persons disclaims beneficial ownership of such shares except to the extent of his or its pecuniary interest therein. Mr. Afeyan is a member of the Issuer's board of directors.
  4. Each share of Series A and Series B Convertible Preferred Stock converted into 1/6.35 of a share of Common Stock upon the closing of the Issuer's initial public offering of common stock for no additional consideration. The preferred shares had no expiration date.